Taipei Exchange - Delayed Quote TWD

Cowealth Medical Holding Co., Ltd. (4745.TWO)

17.55
+0.05
+(0.29%)
At close: 1:30:16 PM GMT+8
Loading Chart for 4745.TWO
  • Previous Close 17.50
  • Open 17.55
  • Bid 17.50 x --
  • Ask 17.65 x --
  • Day's Range 17.50 - 17.90
  • 52 Week Range 15.50 - 27.30
  • Volume 45,644
  • Avg. Volume 61,101
  • Market Cap (intraday) 1.359B
  • Beta (5Y Monthly) 0.35
  • PE Ratio (TTM) --
  • EPS (TTM) -0.45
  • Earnings Date --
  • Forward Dividend & Yield 0.40 (2.29%)
  • Ex-Dividend Date Jun 27, 2024
  • 1y Target Est --

Cowealth Medical Holding Co., Ltd., together with its subsidiaries, engages in trading of medical equipment, reagents, and spare parts in Taiwan, China, and Hong Kong. It operates in two segments, Sells Equipment, and Sells Reagents and Others. The company also offers acme empowerment program, including al-assisted clinical decision support system, platform of management analysis and decision making, multi-channel coaxial-time-audio-video-image digital platform for operating rooms, and cross-trait medical resource platform. In addition, it provides equipment comprising CyberKnife Stereotactic Radiosurgery System, a non-invasive treatment alternative for cancerous and non-cancerous tumors, as well as other medical conditions requiring radiation therapy; LipiView Ocular Surface Interferometer and LipiView Thermal Pulsation System, a system designed to diagnose and address meibomian gland dysfunction; and MRIdian-Linac, an MRI-guided radiation therapy system. Further, the company is involved in general investing; import and export medical equipment, reagents, and spare parts; nutrition, health, and social and economic consulting business; software development, IT equipment maintenance, and IT system maintenance service; and hospital and business management. Cowealth Medical Holding Co., Ltd. was founded in 1997 and is based in George Town, Cayman Islands.

www.cowealthholding.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 4745.TWO

View More

Performance Overview: 4745.TWO

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

4745.TWO
14.18%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
6.00%

1-Year Return

4745.TWO
25.30%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
0.21%

3-Year Return

4745.TWO
30.37%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
34.02%

5-Year Return

4745.TWO
34.38%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
100.28%

Compare To: 4745.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4745.TWO

View More

Valuation Measures

Annual
As of 5/22/2025
  • Market Cap

    1.36B

  • Enterprise Value

    1.57B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.28

  • Price/Book (mrq)

    0.48

  • Enterprise Value/Revenue

    0.40

  • Enterprise Value/EBITDA

    20.49

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.89%

  • Return on Assets (ttm)

    0.08%

  • Return on Equity (ttm)

    -0.38%

  • Revenue (ttm)

    3.94B

  • Net Income Avi to Common (ttm)

    -35.08M

  • Diluted EPS (ttm)

    -0.45

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.15B

  • Total Debt/Equity (mrq)

    9.73%

  • Levered Free Cash Flow (ttm)

    743.41M

Research Analysis: 4745.TWO

View More

Company Insights: 4745.TWO

Research Reports: 4745.TWO

View More

People Also Watch